Implications of atrial fibrillation on the clinical course and outcomes of hospitalized COVID-19 patients: results of the Cardio-COVID-Italy multicentre study.
Sara ParisRiccardo M InciardiCarlo Mario LombardiDaniela TomasoniPietro AmeriValentina CarubelliPiergiuseppe AgostoniClaudia CanaleStefano CarugoGiambattista DanziMattia Di PasqualeFilippo SarulloMaria Teresa La RovereAndrea MortaraMassimo PiepoliItalo PortoGianfranco SinagraMaurizio VolterraniMassimiliano GnecchiSergio LeonardiMarco MerloAnnamaria IorioStefano GiovinazzoAntonio BellasiGregorio ZacconeRita CamporotondoFrancesco CatagnanoLaura Dalla VecchiaGloria MaccagniMassimo MapelliDavide MargonatoLuca MonzoVincenzo NuzziAndrea PozziGiovanni ProvenzaleClaudia SpecchiaChiara TedinoMarco GuazziMichele SenniMarco MetraPublished in: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology (2021)
Among hospitalized patients with COVID-19, a history of AF contributes to worse clinical course with a higher mortality and in-hospital events including new-onset AF, acute HF, and multiorgan failure. The mortality risk remains significant after adjustment for variables associated with COVID-19 severity and comorbidities.
Keyphrases
- atrial fibrillation
- sars cov
- coronavirus disease
- oral anticoagulants
- catheter ablation
- left atrial
- liver failure
- respiratory syndrome coronavirus
- left atrial appendage
- direct oral anticoagulants
- heart failure
- healthcare
- respiratory failure
- drug induced
- percutaneous coronary intervention
- cardiovascular events
- emergency department
- type diabetes
- adipose tissue
- acute care
- adverse drug
- coronary artery disease
- metabolic syndrome
- intensive care unit
- hepatitis b virus
- mitral valve
- aortic dissection
- cardiovascular disease
- acute respiratory distress syndrome
- extracorporeal membrane oxygenation